Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter Vincent Finn, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Weinrauch LA, D'Elia JA, Weir MR, Bunnapradist S, Finn PV, Liu J, Claggett B, Monaco AP. The Reply. Am J Med. 2018 08; 131(8):e349-e351. PMID: 29934217.
    Citations:    Fields:    Translation:Humans
  2. Weinrauch LA, Claggett B, Liu J, Finn PV, Weir MR, Weiner DE, D'Elia JA. Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial. Int J Nephrol Renovasc Dis. 2018; 11:155-164. PMID: 29760559; PMCID: PMC5937486.
    Citations: 9     
  3. Weinrauch LA, Liu J, Claggett B, Finn PV, Weir MR, D'Elia JA. Calcium channel blockade and survival in recipients of successful renal transplant: an analysis of the FAVORIT trial results. Int J Nephrol Renovasc Dis. 2018; 11:1-7. PMID: 29317843; PMCID: PMC5743121.
    Citations: 1     
  4. Bajaj NS, Claggett B, Lewis EF, Desai AS, Fang JC, O'Meara E, Shah SJ, Sweitzer NK, Fleg JL, Pitt B, Rouleau JL, Finn P, Pfeffer MA, Solomon SD. Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fraction. Eur J Heart Fail. 2018 04; 20(4):815-816. PMID: 29067754; PMCID: PMC5899668.
    Citations: 3     Fields:    Translation:Humans
  5. Weinrauch LA, D'Elia JA, Weir MR, Bunnapradist S, Finn PV, Liu J, Claggett B, Monaco AP. Infection and Malignancy Outweigh Cardiovascular Mortality in Kidney Transplant Recipients: Post Hoc Analysis of the FAVORIT Trial. Am J Med. 2018 02; 131(2):165-172. PMID: 28943384.
    Citations: 8     Fields:    Translation:Humans
  6. Weinrauch LA, D'Elia JA, Weir MR, Bunnapradist S, Finn P, Liu J, Claggett B, Monaco AP. Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trial. Int J Nephrol Renovasc Dis. 2017; 10:233-242. PMID: 28860838; PMCID: PMC5571849.
    Citations: 1     
  7. Jarolim P, Claggett BL, Conrad MJ, Carpenter MA, Ivanova A, Bostom AG, Kusek JW, Hunsicker LG, Jacques PF, Gravens-Mueller L, Finn P, Solomon SD, Weiner DE, Levey AS, Pfeffer MA. B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients. Transplantation. 2017 Jan; 101(1):182-190. PMID: 26910333.
    Citations: 5     Fields:    Translation:HumansCells
  8. Weinrauch LA, D'Elia JA, Finn P, Lewis EF, Desai AS, Claggett BL, Cooper ME, McGill JB. Strategies for glucose control in a study population with diabetes, renal disease and anemia (Treat study). Diabetes Res Clin Pract. 2016 Mar; 113:143-51. PMID: 26830074.
    Citations: 5     Fields:    Translation:Humans
  9. Jhund PS, McMurray JJ, Chaturvedi N, Brunel P, Desai AS, Finn PV, Haffner SM, Solomon SD, Weinrauch LA, Claggett BL, Pfeffer MA. Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial. Eur Heart J. 2015 Sep 21; 36(36):2463-9. PMID: 26188211.
    Citations: 7     Fields:    Translation:Humans
  10. Desai AS, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Chen F, Gong J, Rizkala AR, Brahimi A, Claggett B, Finn PV, Hartley LH, Liu J, Lefkowitz M, Shi V, Zile MR, Solomon SD. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Eur Heart J. 2015 Aug 07; 36(30):1990-7. PMID: 26022006.
    Citations: 100     Fields:    Translation:Humans
  11. Charytan DM, Lewis EF, Desai AS, Weinrauch LA, Ivanovich P, Toto RD, Claggett B, Liu J, Hartley LH, Finn P, Singh AK, Levey AS, Pfeffer MA, McMurray JJ, Solomon SD. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2015 Sep; 66(3):429-40. PMID: 25935581; PMCID: PMC4549188.
    Citations: 8     Fields:    Translation:Humans
  12. Desai AS, Claggett B, Pfeffer MA, Bello N, Finn PV, Granger CB, McMurray JJ, Pocock S, Swedberg K, Yusuf S, Solomon SD. Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction. Circ Heart Fail. 2014 Nov; 7(6):895-902. PMID: 25326006.
    Citations: 14     Fields:    Translation:Humans
  13. Ye S, Grunnert M, Thune JJ, Stephenson KM, Uno H, Finn PV, McMurray JJ, Velazquez EJ, Califf R, Pfeffer MA, Solomon SD. Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention. Circulation. 2011 Jun 14; 123(23):2674-80. PMID: 21606398.
    Citations: 3     Fields:    Translation:Humans
  14. Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 2010 Aug 10; 122(6):597-602. PMID: 20660803.
    Citations: 64     Fields:    Translation:HumansCTClinical Trials
  15. Shamshad F, Kenchaiah S, Finn PV, Soler-Soler J, McMurray JJ, Velazquez EJ, Maggioni AP, Califf RM, Swedberg K, Kober L, Belenkov Y, Varshavsky S, Pfeffer MA, Solomon SD. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). Am Heart J. 2010 Jul; 160(1):145-51. PMID: 20598985.
    Citations: 11     Fields:    Translation:Humans
  16. Solomon SD, Wittes J, Finn PV, Fowler R, Viner J, Bertagnolli MM, Arber N, Levin B, Meinert CL, Martin B, Pater JL, Goss PE, Lance P, Obara S, Chew EY, Kim J, Arndt G, Hawk E. Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation. 2008 Apr 22; 117(16):2104-13. PMID: 18378608; PMCID: PMC2965408.
    Citations: 118     Fields:    Translation:Humans
  17. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007 Aug 07; 116(6):627-36. PMID: 17638930.
    Citations: 106     Fields:    Translation:Humans
  18. Solomon SD, Pfeffer MA, McMurray JJ, Fowler R, Finn P, Levin B, Eagle C, Hawk E, Lechuga M, Zauber AG, Bertagnolli MM, Arber N, Wittes J. Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation. 2006 Sep 05; 114(10):1028-35. PMID: 16943394.
    Citations: 80     Fields:    Translation:HumansCTClinical Trials
  19. Janardhanan R, Kenchaiah S, Velazquez EJ, Park Y, McMurray JJ, Weaver WD, Finn PV, White HD, Marin-Neto JA, O'Connor C, Pfeffer MA, Califf RM, Solomon SD. Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. Am Heart J. 2006 Jul; 152(1):183-9. PMID: 16824854.
    Citations: 2     Fields:    Translation:Humans
  20. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005 Jun 23; 352(25):2581-8. PMID: 15972864.
    Citations: 208     Fields:    Translation:Humans
  21. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005 Mar 17; 352(11):1071-80. PMID: 15713944.
    Citations: 523     Fields:    Translation:HumansCTClinical Trials
  22. Solomon SD, Wang D, Finn P, Skali H, Zornoff L, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pocock S, Pfeffer MA. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2004 Oct 12; 110(15):2180-3. PMID: 15466644.
    Citations: 57     Fields:    Translation:HumansCTClinical Trials
  23. Pfeffer JM, Finn PV, Zornoff LA, Pfeffer MA. Endothelin-A receptor antagonism during acute myocardial infarction in rats. Cardiovasc Drugs Ther. 2000 Dec; 14(6):579-87. PMID: 11300358.
    Citations: 10     Fields:    Translation:Animals
  24. Opitz CF, Finn PV, Pfeffer MA, Mitchell GF, Pfeffer JM. Effects of reperfusion on arrhythmias and death after coronary artery occlusion in the rat: increased electrical stability independent of myocardial salvage. J Am Coll Cardiol. 1998 Jul; 32(1):261-7. PMID: 9669279.
    Citations: 5     Fields:    Translation:Animals
  25. Mitchell GF, Pfeffer MA, Finn PV, Pfeffer JM. Comparison of techniques for measuring pulse-wave velocity in the rat. J Appl Physiol (1985). 1997 Jan; 82(1):203-10. PMID: 9029217.
    Citations: 9     Fields:    Translation:Animals
  26. Mitchell GF, Pfeffer MA, Finn PV, Pfeffer JM. Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. Circulation. 1996 Dec 01; 94(11):2923-9. PMID: 8941122.
    Citations: 14     Fields:    Translation:Animals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Finn's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (133)
Co-Authors (12)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.